Weekly Recap | ARKG.US +13.35%, AI healthcare leads genomics themeWeekly Review·2 days ago, 07:15 AMARKG+0.04%
Weekly Recap | Twist Bioscience +31.26%, signs deal with Lilly TuneLabWeekly Review·2 days ago, 06:54 AMTWST-1.40%
Weekly Recap | Medicinova +83.43%, most brokers rate it buyWeekly Review·2 days ago, 06:26 AMMNOV-8.28%
Weekly Recap | ARQT.US +6.26%, consensus target above spotWeekly Review·2 days ago, 05:34 AMARQT+0.47%
Weekly Recap | Alnylam Pharma -3.67%, consensus target above spotWeekly Review·2 days ago, 05:31 AMALNY+1.93%
The Nasdaq Biotechnology Index closed up nearly 1.4%, closely mirroring the performance of the Dow Jones Industrial Average. Among the constituent stocks, Esperion rose 16.09%, ARS Pharmaceuticals rose 15.50%, Anavex Life Sciences rose 12.34%, Personalis rose 12.31%, Autolus Therapeutics rose 12.10%, and Aura Biosciences rose 11.09%. AC Immune fell 5.84%, LENZ Therapeutics fell 6.51%, and Cullinan Oncology LLC fell 8.82%Wallstreetcn·Nov 25, 2025 at 09:27 PMPSNL-1.89%SPRY+2.68%
